Skip to main content
Clinical Trials/NCT00210171
NCT00210171
Withdrawn
Phase 2

Multicentric Phase II Study of Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer, With :- Induction Chemotherapy by Cisplatin - Docetaxel- Concomitant Chemo-radiotherapy by Weekly Cisplatin - Docetaxel- Consolidation Chemotherapy by Docetaxel

Institut Bergonié7 sites in 1 country3 target enrollmentMay 1, 2004

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Carcinoma, Non-Small-Cell Lung
Sponsor
Institut Bergonié
Enrollment
3
Locations
7
Primary Endpoint
Objective response
Status
Withdrawn
Last Updated
7 months ago

Overview

Brief Summary

Feasibility of pragmatic concomitant chemo-radiotherapy association with 1 cycle of Induction chemotherapy, weekly chemo-radiotherapy, and consolidation chemotherapy.

Registry
clinicaltrials.gov
Start Date
May 1, 2004
End Date
May 1, 2004
Last Updated
7 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Objective response

Time Frame: 6 months

Study Sites (7)

Loading locations...

Similar Trials